Канада - английский - Health Canada

lab nadeau ltÉe, division of technilab inc. - diiodohydroxyquin; sulfadiazine; undecylenic acid - suppository - 75mg; 400mg; 50mg - diiodohydroxyquin 75mg; sulfadiazine 400mg; undecylenic acid 50mg - miscellaneous antifungals

Канада - английский - Health Canada

glenwood laboratories canada ltd. - diiodohydroxyquin - tablet - 210mg - diiodohydroxyquin 210mg - amebicides

Канада - английский - Health Canada

glenwood laboratories canada ltd. - diiodohydroxyquin - tablet - 650mg - diiodohydroxyquin 650mg - amebicides

Канада - английский - Health Canada

paladin labs inc. - clioquinol; flumethasone pivalate - cream - 3%; 0.02% - clioquinol 3%; flumethasone pivalate 0.02% - anti-inflammatory agents

Канада - английский - Health Canada

paladin labs inc. - clioquinol; hydrocortisone - cream - 3%; 1% - clioquinol 3%; hydrocortisone 1% - anti-inflammatory agents

Соединенные Штаты - английский - NLM (National Library of Medicine)

crown laboratories - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 5 mg in 1 g

Соединенные Штаты - английский - NLM (National Library of Medicine)

crown laboratories - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), clioquinol (unii: 7bhq856ej5) (clioquinol - unii:7bhq856ej5) - hydrocortisone 5 mg in 1 g - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: “possibly” effective: contact or atopic dermatitis; impetiginized eczema; nummular eczema; infantile eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. final classification of the less-than-effective indications requires further investigation. hypersensitivity to lodochlorhydroxyquin-hydrocortisone, or any of its ingredients or related compounds: lesions of the eye, tuberculosis of the skin; most viral skin lesions (including herpes simplex, vaccinia, and varicella). patients sensitive to chloroxine, iodine, or iodi

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ge healthcare limited - indium oxine (in-111) - radio-pharm precursor

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ge healthcare limited - indium oxine (in-111) - radio-pharm precursor - %v/v